tirzepatide is that mounjaro 2.5 mg / 0.5 ml Vial - Mounjaro (Tirzepatide): Raising the Bar

The potential mechanisms underlying the increased risk of gastric aspiration are not fully understood, and nowadays it is explained mainly by delayed gastric emptying and inhibition of gastrointestinal motor function that GLP-1-RAs exert through both central motor nuclei and vagal afferents [13, 14]

It can also increase the levels of serum growth hormone by 200-1000%, which usually lasts for up to 6 days

Koehler JA, Baggio LL, Lamont BJ, Ali S, Drucker DJ

In June 2024 , Eli Lilly and Company (NYSE: LLY) reported detailed results from the SURMOUNT-OSA Phase III clinical trials evaluating tirzepatide injection (10 mg or 15 mg) for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, with and without positive airway pressure (PAP) therapy

There is nothing thats really all benefit and no risk